VALETTI, CATERINA
VALETTI, CATERINA
100008 - Dipartimento di medicina sperimentale
A virtuous cycle operated by ERp44 and ERGIC-53 guarantees proteostasis in the early secretory compartment
2021-01-01 Tempio, T.; Orsi, A.; Sicari, D.; Valetti, C.; Yoboue, E. D.; Anelli, T.; Sitia, R.
CLIP-170 interacts with dynactin complex and the APC-binding protein EB1 by different mechanisms.
2003-01-01 H. V., Goodson; S. B., Skube; R., Stalder; Valetti, Caterina; T. E., Kreis; E. E., Morrison; T. A., Schroer
Controllo post-trascrizionale dell'espressione genica.
1990-01-01 P., Bet; Valetti, Caterina; R., Sitia
Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1.
2000-01-01 M., D'Addio; A., Pizzigoni; M. T., Bassi; C., Baschirotto; Valetti, Caterina; B., Incerti; M., Clementi; M., DE LUCA; A., Ballabio; M. V., Schiaffino
Developmental regulation of IgM secretion: the role of the carboxy-terminal cysteine.
1990-01-01 R., Sitia; M., Neuberger; C., Alberini; P., Bet; A., Fra; Valetti, Caterina; G., Williams; C., Milstein
ER storage diseases: a role for ERGIC-53 in controlling the formation and shape of Russell bodies.
2006-01-01 Mattioli, Laura; T., Anelli; C., Fagioli; Tacchetti, Carlo; R., Sitia; Valetti, Caterina
Inadequate BiP availability defines endoplasmic reticulum stress
2019-01-01 Vitale, M.; Bakunts, A.; Orsi, A.; Lari, F.; Tade, L.; Danieli, Antonella; Rato, C.; Valetti, C.; Sitia, R.; Raimondi, A.; Christianson, J. C.; Van Anken, E.
Melanosome-autonomous regulation of size and number: the OA1 receptor sustains PMEL expression.
2014-01-01 Falletta, P; Bagnato, Paola; Bono, M; Monticone, M; Schiaffino, Mv; Bennett, Dc; Goding, Cr; Tacchetti, Carlo; Valetti, Caterina
Modulating secretion of antibodies.
1991-01-01 A. M., Fra; C., Alberini; P., Bet; D., Finazzi; Valetti, Caterina; R., Sitia
Motors and membrane traffic.
1997-01-01 H. V., Goodson; Valetti, Caterina; T. E., Kreis
Ocular Albinism: evidence for a defect in an intracellular signal transduction system
1999-01-01 Schiaffino, Mv; D'Addio, M; Alloni, A; Baschirotto, C; Valetti, Caterina; Cortese, Katia; Puri, C; Bassi, Mt; Colla, C; DE LUCA, M; Tacchetti, Carlo; Ballabio, A.
Organelle-autonomous regulation of size and number: OA1 receptor sustains Pmel17 expression
2011-01-01 P., Falletta; M., Bono; P., Bagnato; M., Monticone; D. C., Bennett; M. V., Schiaffino; C. R., Goding; Tacchetti, Carlo; Valetti, Caterina
Purification and analysis of authentic CLIP-170 and recombinant fragments.
1999-01-01 J., Scheel; P., Pierre; J. E., Rickard; G. S., Diamantopoulos; Valetti, Caterina; F. G., VAN DER GOOT; M., Haner; U., Aebi; T. E., Kreis
Role of dynactin in endocytic traffic: effects of dynamitin overexpression and colocalization with CLIP-170.
1999-01-01 Valetti, Caterina; D. M., Wetzel; M., Schrader; M. J., Hasbani; S. R., Gill; T. E., Kreis; T. A., Schroer
Roles of N-glycans in the polymerization-dependent aggregation of mutant Ig-μ chains in the early secretory pathway
2017-01-01 Giannone, Chiara; Fagioli, Claudio; Valetti, Caterina; Sitia, Roberto; Anelli, Tiziana
Russell bodies as a model of ER storage diseases
2013-01-01 B., Sterlini; T., Anelli; Tacchetti, Carlo; R., Sitia; Valetti, Caterina
Russell bodies: a general response of secretory cells to synthesis of a mutant immunoglobulin which can neither exit from, nor be degraded in, the endoplasmic reticulum
1991-01-01 Valetti, Caterina; Grossi, CARLO ENRICO; C., Milstein; R., Sitia
Sequential steps and checkpoints in the early exocytic compartment during secretory IgM biogenesis.
2007-01-01 T., Anelli; S., Ceppi; L., Bergamelli; M., Cortini; S., Masciarelli; Valetti, Caterina; R., Sitia
The differential effects of dithiothreitol and 2-mercaptoethanol on the secretion of partially and completely assembled immunoglobulins suggest that thiol-mediated retention does not take place in or beyond the Golgi.
1994-01-01 Valetti, Caterina; R., Sitia
The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: A possible impact on the natural history of the disease.
2010-01-01 M., Marchesi; C., Parolini; Valetti, Caterina; P., Mangione; L., Obici; S., Giorgetti; S., Raimondi; S., Donadei; G., Gregorini; G., Merlini; M., Stoppini; G., Chiesa; V., Bellotti
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A virtuous cycle operated by ERp44 and ERGIC-53 guarantees proteostasis in the early secretory compartment | 1-gen-2021 | Tempio, T.; Orsi, A.; Sicari, D.; Valetti, C.; Yoboue, E. D.; Anelli, T.; Sitia, R. | |
CLIP-170 interacts with dynactin complex and the APC-binding protein EB1 by different mechanisms. | 1-gen-2003 | H. V., Goodson; S. B., Skube; R., Stalder; Valetti, Caterina; T. E., Kreis; E. E., Morrison; T. A., Schroer | |
Controllo post-trascrizionale dell'espressione genica. | 1-gen-1990 | P., Bet; Valetti, Caterina; R., Sitia | |
Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1. | 1-gen-2000 | M., D'Addio; A., Pizzigoni; M. T., Bassi; C., Baschirotto; Valetti, Caterina; B., Incerti; M., Clementi; M., DE LUCA; A., Ballabio; M. V., Schiaffino | |
Developmental regulation of IgM secretion: the role of the carboxy-terminal cysteine. | 1-gen-1990 | R., Sitia; M., Neuberger; C., Alberini; P., Bet; A., Fra; Valetti, Caterina; G., Williams; C., Milstein | |
ER storage diseases: a role for ERGIC-53 in controlling the formation and shape of Russell bodies. | 1-gen-2006 | Mattioli, Laura; T., Anelli; C., Fagioli; Tacchetti, Carlo; R., Sitia; Valetti, Caterina | |
Inadequate BiP availability defines endoplasmic reticulum stress | 1-gen-2019 | Vitale, M.; Bakunts, A.; Orsi, A.; Lari, F.; Tade, L.; Danieli, Antonella; Rato, C.; Valetti, C.; Sitia, R.; Raimondi, A.; Christianson, J. C.; Van Anken, E. | |
Melanosome-autonomous regulation of size and number: the OA1 receptor sustains PMEL expression. | 1-gen-2014 | Falletta, P; Bagnato, Paola; Bono, M; Monticone, M; Schiaffino, Mv; Bennett, Dc; Goding, Cr; Tacchetti, Carlo; Valetti, Caterina | |
Modulating secretion of antibodies. | 1-gen-1991 | A. M., Fra; C., Alberini; P., Bet; D., Finazzi; Valetti, Caterina; R., Sitia | |
Motors and membrane traffic. | 1-gen-1997 | H. V., Goodson; Valetti, Caterina; T. E., Kreis | |
Ocular Albinism: evidence for a defect in an intracellular signal transduction system | 1-gen-1999 | Schiaffino, Mv; D'Addio, M; Alloni, A; Baschirotto, C; Valetti, Caterina; Cortese, Katia; Puri, C; Bassi, Mt; Colla, C; DE LUCA, M; Tacchetti, Carlo; Ballabio, A. | |
Organelle-autonomous regulation of size and number: OA1 receptor sustains Pmel17 expression | 1-gen-2011 | P., Falletta; M., Bono; P., Bagnato; M., Monticone; D. C., Bennett; M. V., Schiaffino; C. R., Goding; Tacchetti, Carlo; Valetti, Caterina | |
Purification and analysis of authentic CLIP-170 and recombinant fragments. | 1-gen-1999 | J., Scheel; P., Pierre; J. E., Rickard; G. S., Diamantopoulos; Valetti, Caterina; F. G., VAN DER GOOT; M., Haner; U., Aebi; T. E., Kreis | |
Role of dynactin in endocytic traffic: effects of dynamitin overexpression and colocalization with CLIP-170. | 1-gen-1999 | Valetti, Caterina; D. M., Wetzel; M., Schrader; M. J., Hasbani; S. R., Gill; T. E., Kreis; T. A., Schroer | |
Roles of N-glycans in the polymerization-dependent aggregation of mutant Ig-μ chains in the early secretory pathway | 1-gen-2017 | Giannone, Chiara; Fagioli, Claudio; Valetti, Caterina; Sitia, Roberto; Anelli, Tiziana | |
Russell bodies as a model of ER storage diseases | 1-gen-2013 | B., Sterlini; T., Anelli; Tacchetti, Carlo; R., Sitia; Valetti, Caterina | |
Russell bodies: a general response of secretory cells to synthesis of a mutant immunoglobulin which can neither exit from, nor be degraded in, the endoplasmic reticulum | 1-gen-1991 | Valetti, Caterina; Grossi, CARLO ENRICO; C., Milstein; R., Sitia | |
Sequential steps and checkpoints in the early exocytic compartment during secretory IgM biogenesis. | 1-gen-2007 | T., Anelli; S., Ceppi; L., Bergamelli; M., Cortini; S., Masciarelli; Valetti, Caterina; R., Sitia | |
The differential effects of dithiothreitol and 2-mercaptoethanol on the secretion of partially and completely assembled immunoglobulins suggest that thiol-mediated retention does not take place in or beyond the Golgi. | 1-gen-1994 | Valetti, Caterina; R., Sitia | |
The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: A possible impact on the natural history of the disease. | 1-gen-2010 | M., Marchesi; C., Parolini; Valetti, Caterina; P., Mangione; L., Obici; S., Giorgetti; S., Raimondi; S., Donadei; G., Gregorini; G., Merlini; M., Stoppini; G., Chiesa; V., Bellotti |